GILL DAVID N — SEC Form 4 filings
SEC reporting owner CIK 1106519. 7 Form 4 filings on record with FilingPulse; latest filed 2026-02-19.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-09 to 2026-02-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 10,361 shares, $131,010 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 6,718 shares @ $12.60 ($84,654) in Evolus, Inc., filed 2024-05-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Evolus, Inc. (EOLS) | Director | 4 | — | 2 legs · 10,361 sh · $131,010 | 5 |
| Y-mAbs Therapeutics, Inc. (YMAB) | Director | 3 | — | — | 14 |
Form 4 filings — GILL DAVID N
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-19 | 4 | Evolus, Inc. (EOLS) | Grant/award (A): 45,559 @ $0 | EDGAR |
| 2025-09-18 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Disposition to issuer (D): 5,825 @ $8.60 · Disposition to issuer (D): 25,080 · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 16,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · +4 more | EDGAR |
| 2025-07-02 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/award (A): 25,080 @ $0 · Grant/award (A): 33,450 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Evolus, Inc. (EOLS) | Grant/award (A): 7,364 @ $0 · Grant/award (A): 11,146 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/award (A): 3,495 @ $0 · Grant/award (A): 14,545 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | Evolus, Inc. (EOLS) | Sale (S): 3,643 @ $12.72 · Sale (S): 6,718 @ $12.60 | EDGAR |
| 2024-02-09 | 4 | Evolus, Inc. (EOLS) | Grant/award (A): 6,464 @ $0 · Grant/award (A): 9,377 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1106519 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →